Business Description
Singular Genomics Systems Inc
NAICS : 334516
SIC : 3841
ISIN : US82933R1005
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.86 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.52 | |||||
Debt-to-EBITDA | -0.86 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -2.83 | |||||
Beneish M-Score | -2.83 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -45.8 | |||||
3-Year EPS without NRI Growth Rate | -48.1 | |||||
3-Year FCF Growth Rate | -39.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 11.93 | |||||
Future 3-5Y Total Revenue Growth Rate | 110.63 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.71 | |||||
9-Day RSI | 60.14 | |||||
14-Day RSI | 63.68 | |||||
6-1 Month Momentum % | -59.84 | |||||
12-1 Month Momentum % | -46.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.77 | |||||
Quick Ratio | 8.04 | |||||
Cash Ratio | 7.86 | |||||
Days Inventory | 1270.88 | |||||
Days Sales Outstanding | 42.19 | |||||
Days Payable | 199.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.8 | |||||
Shareholder Yield % | -46.62 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -41.11 | |||||
Operating Margin % | -3654.37 | |||||
Net Margin % | -3375.72 | |||||
FCF Margin % | -2864.95 | |||||
ROE % | -51.57 | |||||
ROA % | -35.53 | |||||
ROIC % | -117.3 | |||||
ROC (Joel Greenblatt) % | -119.83 | |||||
ROCE % | -37.43 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 13.83 | |||||
PB Ratio | 0.28 | |||||
Price-to-Tangible-Book | 0.27 | |||||
EV-to-EBIT | 0.26 | |||||
EV-to-Forward-EBIT | -0.04 | |||||
EV-to-EBITDA | 0.28 | |||||
EV-to-Forward-EBITDA | -0.05 | |||||
EV-to-Revenue | -8.69 | |||||
EV-to-Forward-Revenue | 0.38 | |||||
EV-to-FCF | 0.36 | |||||
Price-to-Net-Current-Asset-Value | 0.57 | |||||
Price-to-Net-Cash | 0.74 | |||||
Earnings Yield (Greenblatt) % | 384.62 | |||||
FCF Yield % | -204.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OMIC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Singular Genomics Systems Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2.722 | ||
EPS (TTM) ($) | -37.37 | ||
Beta | 1.38 | ||
Volatility % | 133.48 | ||
14-Day RSI | 63.68 | ||
14-Day ATR ($) | 1.412919 | ||
20-Day SMA ($) | 14.33375 | ||
12-1 Month Momentum % | -46.92 | ||
52-Week Range ($) | 5.34 - 19.8 | ||
Shares Outstanding (Mil) | 2.5 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Singular Genomics Systems Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Singular Genomics Systems Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Singular Genomics Systems Inc Frequently Asked Questions
What is Singular Genomics Systems Inc(OMIC)'s stock price today?
When is next earnings date of Singular Genomics Systems Inc(OMIC)?
Does Singular Genomics Systems Inc(OMIC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |